Federal Register / Vol. 73, No. 201 / Thursday, October 16, 2008 / Notices 61427 

requirement in its information 

collection request, but had not included 

the recordkeeping requirement of the 

medical log. In addition, CDC is 

changing the requirement from 

reporting gastrointestinal illness to 

reporting all diseases of public health 

significance. This submission includes 

the medical log recordkeeping 

requirement, for an additional 2,375 

burden hours. 

Respondents include airline pilots, 

ships’ captains, importers, medical 

professionals, and travelers. The nature 

of the quarantine response dictates 

which forms are completed by whom. 

There are no costs to respondents 

except their time to complete the forms. 

ESTIMATE OF ANNUALIZED BURDEN HOURS

Citation Number of 

respondents 

Responses per 

respondent 

Average burden 

per respondent 

(in hours) 

Total burden 

(in hours) 

71.21 Radio report death/illness ................................................... 9,500 1 2/60 317 

71.21(c) Medical log ...................................................................... 9,500 1 15/60 2,375 

71.3 Designation of yellow fever vaccination centers ................... 500 1 1 500 

71.33(c) Report by person(s) in isolation or surveillance ............. 11 1 3/60 1 

71.35 Report of death/illness in port ............................................. 5 1 30/60 3 

Outbreak of public health significance ............................................ 2,700,000 1 5/60 225,000 

Reporting of ill passenger(s) ........................................................... 800 1 5/60 67 

71.51(b)(3) Admission of cats/dogs; death/illness ........................ 5 1 3/60 1 

71.51(d) Dogs/cats; certification of confinement, vaccination ....... 1,200 1 15/60 300 

71.52(d) Turtle importation permits ............................................... 10 1 30/60 5 

71.53(d) Importer registration—nonhuman primates .................... 40 1 10/60 67 

71.53(d) Recordkeeping ................................................................ 30 4 30/60 60 

71.55 Permit for dead body .......................................................... 5 1 1 5 

71.56(a)(ii) Request for exemption ............................................... 12 1 1 12 

71.56(a)(iii) Appeal ........................................................................ 5 1 1 5 

71.56(c) Appeal ............................................................................. 5 1 1 5 

Total .......................................................................................... ............................ ............................ ............................ 228,723 

Dated: October 1, 2008. 

Maryam I. Daneshvar, 

Reports Clearance Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. E8–24568 Filed 10–15–08; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Healthcare Infection Control Practices 

Advisory Committee, (HICPAC) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting for the 

aforementioned committee: 

Times and Dates: 

9 a.m.–5 p.m., November 13, 2008. 

9 a.m.–1 p.m., November 14, 2008. 

Place: The Washington Marriott, 1221 

22nd Street, NW., Washington, DC 20037. 

Status: Open to the public, limited only by 

the space available. 

Purpose: The Committee is charged with 

providing advice and guidance to the 

Secretary, the Assistant Secretary for Health, 

the Director, CDC, and the Director, National 

Center for Preparedness, Detection, and 

Control of Infectious Diseases (NCPDCID), 

regarding (1) The practice of hospital 

infection control; (2) Strategies for 

surveillance, prevention, and control of 

infections (e.g., nosocomial infections), 

antimicrobial resistance, and related events 

in settings where healthcare is provided; and 

(3) Periodic updating of guidelines and other 

policy statements regarding prevention of 

healthcare-associated infections and 

healthcare-related conditions. 

Matters To Be Discussed: The agenda will 

include a follow-up discussion of Health and 

Human Services Healthcare-Associated 

Infections Elimination Process, Urinary Tract 

Infections Guideline, and Norovirus 

Guideline. 

Agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: 

Wendy Vance, HICPAC, Division of 

Healthcare Quality Promotion, NCPDCID, 

CDC, l600 Clifton Road, NE., Mailstop D–10, 

Atlanta, Georgia 30333 Telephone (404) 639– 

2891. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: October 7, 2008. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention (CDC). 

[FR Doc. E8–24563 Filed 10–15–08; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

National Center for Injury Prevention 

and Control/ Initial Review Group, 

(NCIPC/IRG) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting of the 

aforementioned review group: 

Times and Dates: 

7 p.m.–8 p.m., November 18, 2008 (Open). 

7:45 a.m.–5 p.m., November 19, 2008 

(Closed). 

7:45 a.m.–5 p.m., November 20, 2008 

(Closed). 

7:45 a.m.–5 p.m., November 21, 2008 

(Closed). 

Place: The W Hotel, 3377 Peachtree Road, 

NE., Atlanta, Georgia 30326, Telephone: 

(678) 500–3181. 

Status: Portions of the meetings will be 

closed to the public in accordance with 

provisions set forth in Section 552b(c)(4) and 

(6), Title 5, U.S.C., and the Determination of 

the Director, Management Analysis and 

Services Office, CDC, pursuant to Section 

10(d) of Public Law 92–463. 

Purpose: This group is charged with 

providing advice and guidance to the 

Secretary, Department of Health and Human 

Services, and the Director, CDC, concerning 

the scientific and technical merit of grant and 

cooperative agreement applications received